| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.18 | 7e-06 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.22 | 1e-05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.3 | 1e-05 |